Adapting to Change: Incorporating Telemedicine into Our Practice - For the Optometrist

Supported by an unrestricted educational grant from Eyevance.

Learning Objectives

Upon completion of this activity, the participant should be able to:

This initiative is designed to address and resolve the educational needs through the following educational objectives:

• Formulate a plan to implement telemedicine into an eye care practice.
• Describe how telemedicine can provide care for patients who cannot be seen in the office, whether due to a pandemic or physical limitations of patient.
• Summarize how to bill and code for telemedicine services.

 

Accreditation and Designation Statement

Sponsored by:

Evolve is an approved COPE Administrator.
This course is COPE approved for .75 hour of CE credit for optometrists.

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

 

Course Viewing Requirements

Supported Browsers:

Internet Explorer 11 for Windows

Edge (recent versions; Chromium-based) for Windows

Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:

4GB+ RAM

Recommended internet speed 5Mbps+

Faculty and Disclosures

Faculty:

 

Jack Chapman, MD

Gainesville Eye Associates

Gainesville, GA

 

 

 

Ranjan P. Malhotra, MD, FACS

Ophthalmology Associates

St. Louis, MO

 

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Jack Chapman, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Eyevance and Sun Pharma. Speaker’s Bureau: Alcon, Johnson & Johnson Vision and Sun Pharma.

Ranjan P. Malhotra, MD, FACS, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Aimmax Therapeutics, Carl Zeiss Meditec, Hovione, Kala Pharmaceuticals, Insite Pharmaceuticals, Ocugen, Perrigo, Sight Sciences, and Silk Tech,  Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Biotissue, EyePoint, Eyevance, Kala Pharmaceuticals, Novartis and Sun Pharma.

 

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Eyevance.